Main Responsibilities of the National Medical Products Administration
(1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics.
(2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system.
(3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof.
(4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA’s responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.
(5) To undertake post-market risk management for drugs, medical devices and cosmetics; to organize the monitoring, evaluation, and handling of adverse drug reactions, medical device adverse events, and cosmetic adverse reactions; to undertake emergency response management for drugs, medical devices and cosmetics in accordance with law.
(6) To undertake management of qualifications for licensed pharmacists; to formulate regulations of qualifications for licensed pharmacists, and guide and supervise the registration of licensed pharmacists.
(7) To organize and guide the supervision and inspection of drugs, medical devices and cosmetics; to develop the inspection system, investigate and punish illegal activities during the registration process for drugs, medical devices and cosmetics in accordance with law, and organize and guide the investigation and punishment of illegal activities during the manufacturing process in line with NMPA’s responsibilities.
(8) To engage in international exchange and cooperation in the regulation of drugs, medical devices and cosmetics, and participate in developing relevant international regulatory rules and standards.
(9) To guide the work of drug regulatory departments of all provinces, autonomous regions, and municipalities directly under the Central Government.
(10) To complete other tasks assigned by the CPC Central Committee and the State Council.
下一篇:原卫生部《进口非特殊用途化妆品备案凭证》 »
相关文章:
- [ABOUT]Cooperation Process of Imported Cosmetics Registration
- [ABOUT]Documents Preparation
- [ABOUT]Procedure
- [ABOUT]EVENTS
- [ABOUT]Commitments
- [ABOUT]Cooperation cases
- [ABOUT]Contact Us
- [ABOUT]Services
- [ABOUT]BeijingTianjianhuacheng International Investment Co.,Ltd
- [ABOUT]How to choose a professional agency?
相关推荐:
- [常见问题]此前在自贸试验区已完成备案的进口非特殊用途化妆品,后续如何开展事中事后监管?
- [化妆品新原料]化妆品新原料行政许可申报流程
- [审批动态]2022年04月06日化妆品批准证明文件待领取信息发布
- [申报资讯]国家食药监局更改核酸类保健食品不适宜人群
- [よくある質問]輸入特殊用途化粧品の行政許可を申請する場合、次の資料を提出する
- [审批动态]2024年12月06日化妆品申报决定书送达信息
- [审批动态]2023年12月22日化妆品注册决定书送达信息发布
- [审批动态]2024年08月27日化妆品注册批准证明文件(变更、纠错)送达信息
- [申报资讯]福建药监局拟取消74家未提交普通化妆品年度报告企业的产品备案
- [常见问题]化妆品备案资料电子化后,原先有提交要求的资料如何处理?
-
86-010-84828041/42
400-6167-168
zhuceabc@zhuceabc.com
咨询微信:
13601366497(化妆品类)
1801335159(特殊食品类)







